ANVISA’s home brewed scaling? [RSABE / ABEL]

posted by ElMaestro  – Denmark, 2015-05-28 21:10 (3580 d 19:50 ago) – Posting: # 14878
Views: 9,870

Hi Helmut,

❝ […] in the cases that the intra-subject coefficient of variation (CV%) exceeds 40% for the originator product.


Haha, for a moment I thought you were serious. But then realised that of course no agency will be enforcing such a weird and unjustified requirement.

You almost had me there. Great sense of humour.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,409 posts in 4,921 threads, 1,666 registered users;
27 visitors (0 registered, 27 guests [including 10 identified bots]).
Forum time: 16:00 CET (Europe/Vienna)

There are only two kinds of scholars;
those who love ideas and those who hate them.    Emile Chartier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5